Position in TEVA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$31,677,204
-$1,296,161 QoQ
Shares Held
1,051,700
-0.5% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Derivatives in TEVA
reported options exposure · as of Dec 31, 2022CallValue
$5,654,400
CallShares
620,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BECK MACK & OLIVER LLC holds $32,081,968 across 3 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (98.7% of the industry book) .
All Filings in TEVA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,677,204 | 1,051,700 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $32,973,365 | 1,056,500 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $22,158,996 | 1,096,980 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,418,988 | 1,098,985 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,994,196 | 1,170,735 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $26,392,679 | 1,197,490 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $22,230,373 | 1,233,650 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $21,243,625 | 1,307,300 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $26,717,158 | 1,893,491 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $25,392,314 | 2,432,214 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $32,406,542 | 3,177,112 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,144,775 | 3,737,686 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $50,406,573 | 5,695,658 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $58,042,716 | 6,364,333 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $5,654,400 | 620,000 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $60,823,468 | 7,536,985 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $48,670,530 | 6,472,145 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $59,509,312 | 6,337,520 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $43,997,111 | 5,492,773 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $71,746,553 | 7,366,176 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $44,017,290 | 4,446,191 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $47,214,397 | 4,091,369 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $37,739,952 | 3,910,876 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $36,778,243 | 4,081,936 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $49,340,443 | 4,001,658 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $35,583,097 | 3,962,483 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||